Nautilus Biotechnology Inc (NAUT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 20,789 | 21,607 | 20,001 | 19,075 | 19,016 |
| Operating Income | -20,789 | -21,607 | -20,001 | -19,075 | -19,016 |
| Other Income | 2,779 | 2,877 | 2,977 | 3,197 | 3,208 |
| Pre-tax Income | -18,010 | -18,730 | -17,024 | -15,878 | -15,808 |
| Net Income Continuous | -18,010 | -18,730 | -17,024 | -15,878 | -15,808 |
| Net Income | $-18,010 | $-18,730 | $-17,024 | $-15,878 | $-15,808 |
| EPS Basic Total Ops | -0.14 | -0.15 | -0.13 | -0.13 | -0.13 |
| EPS Basic Continuous Ops | -0.14 | -0.15 | -0.14 | -0.13 | -0.13 |
| EPS Diluted Total Ops | -0.14 | -0.15 | -0.13 | -0.13 | -0.13 |
| EPS Diluted Continuous Ops | -0.14 | -0.15 | -0.14 | -0.13 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.14 | -0.15 | -0.14 | N/A | N/A |
| EBITDA(a) | $-19,894 | $-20,767 | $-19,030 | $-18,220 | $-18,298 |